LoginSubscribe Now
International In-house Counsel Journal Logo
International In-house Counsel Journal Logo
  • Home
  • Business Sectors
  • Areas of Law
  • Editorial Board
  • Write a Paper
  • Subscribe
  • Books
  • Reports
  • Back Issues
  • Terms and Conditions
  • Cookie Policy
  • Privacy Policy
  • PLS LogoCopyright & permissions
© 2026 International In-house Counsel Journal Ltd. | ISSN 1754-0607 | Picture Credits: Freepix, Unsplash and by permission of the authors
Back to library search

Self-Regulation of an Industry versus the Rule of Law

April 2013RegulationPharmaceutical

Abstract

Self-regulation is an honourable concept. Proponents of the system emphasise the relative amiability and expediency of dispute resolution mechanisms, and remind industry that to the extent that it is not satisfied with the relevant self-regulatory body, that it has the power to effect the necessary changes to the system because such system derives its very power from the industry. However, self-regulation becomes difficult and hostile when the regulatory body starts to become more stringent and impose more onerous restrictions than the law in place at the time. When common law rights become eroded through self-regulation, a return to the rule of law becomes necessary for the long-term viability of the industry or sector concerned.

Subscribe to reador
PLS Logo Copyright & permissions

Author

Howard Snoyman

Head: Legal and Ethics, Discovery Health Medical Scheme, South Africa

Related Papers

Increased Evolution of Regulations Affecting the Pharmaceutical Law Practice
The increase of regulations over the last two to five years for pharmaceutical companies has become a nightmare for sales representatives working for those companies and for internal staff charged...Read more
Portrait image of Jean Frydman
Jean Frydman
Partner, Fox Rothschild, USA
The Globalization of Clinical Trials - Challenges, Opportunities and a Path Forward
In recent years, pharmaceutical companies have expanded clinical research in emerging markets around the world and increasingly involving populations that traditionally have had limited or no access to clinical trials...Read more
Portrait image of Marc Wilenzick
Marc Wilenzick
Chief Compliance Counsel, R&D, Pfizer Inc, USA
Portrait image of Justin McCarthy
Justin McCarthy
SVP Global Policy and International Public Affairs, Pfizer Inc., USA
Portrait image of Cara Cuenot
Cara Cuenot
Lead counsel for the BioCorrection Research Unit, Pfizer Inc, USA
Left to Their Own Devices
The European Union (“EU”) has among its most fundamental goals and principles a convergence of the economies of, and a weakening of internal frontiers between, its member states. Economic...Read more
Portrait image of Patrik Plöen
Patrik Plöen
Head of Legal, Internationa, Markets, Nestlé Skin Health, Sweden
United States Jurisdiction Abroad
The United States applies their jurisdiction abroad under several instances. This is something very important for U.S. based corporations with global operations to understand, since there might be in a...Read more
Portrait image of Fabiana Lacerca-Allen
Fabiana Lacerca-Allen
Chief Compliance Officer, Cipla, USA